_version_ 1784831243111628800
author Mourão Toreli, Ana Carolina
Fechio, Leonardo
Duarte, Adriana Silva Santos
Basso, Audrey
Duarte, Gislaine B O
Medina, Samuel de Souza
Amarante, Guilherme Brasil Duffles
Pericole, Fernando Vieira
Benites, Bruno Deltreggia
Zulli, Roberto
Souza, Carmino Antonio
Addas Carvalho, Marcelo
Pagnano, Katia B
author_facet Mourão Toreli, Ana Carolina
Fechio, Leonardo
Duarte, Adriana Silva Santos
Basso, Audrey
Duarte, Gislaine B O
Medina, Samuel de Souza
Amarante, Guilherme Brasil Duffles
Pericole, Fernando Vieira
Benites, Bruno Deltreggia
Zulli, Roberto
Souza, Carmino Antonio
Addas Carvalho, Marcelo
Pagnano, Katia B
author_sort Mourão Toreli, Ana Carolina
collection PubMed
description
format Online
Article
Text
id pubmed-9665222
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652222022-11-16 Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center Mourão Toreli, Ana Carolina Fechio, Leonardo Duarte, Adriana Silva Santos Basso, Audrey Duarte, Gislaine B O Medina, Samuel de Souza Amarante, Guilherme Brasil Duffles Pericole, Fernando Vieira Benites, Bruno Deltreggia Zulli, Roberto Souza, Carmino Antonio Addas Carvalho, Marcelo Pagnano, Katia B Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665222/ http://dx.doi.org/10.1182/blood-2022-168108 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Online Publication Only
Mourão Toreli, Ana Carolina
Fechio, Leonardo
Duarte, Adriana Silva Santos
Basso, Audrey
Duarte, Gislaine B O
Medina, Samuel de Souza
Amarante, Guilherme Brasil Duffles
Pericole, Fernando Vieira
Benites, Bruno Deltreggia
Zulli, Roberto
Souza, Carmino Antonio
Addas Carvalho, Marcelo
Pagnano, Katia B
Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title_full Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title_fullStr Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title_full_unstemmed Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title_short Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
title_sort serological response after two doses of sars-cov-2 vaccines in cml patients - a prospective study of a brazilian center
topic Online Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665222/
http://dx.doi.org/10.1182/blood-2022-168108
work_keys_str_mv AT mouraotorelianacarolina serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT fechioleonardo serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT duarteadrianasilvasantos serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT bassoaudrey serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT duartegislainebo serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT medinasamueldesouza serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT amaranteguilhermebrasilduffles serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT pericolefernandovieira serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT benitesbrunodeltreggia serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT zulliroberto serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT souzacarminoantonio serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT addascarvalhomarcelo serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter
AT pagnanokatiab serologicalresponseaftertwodosesofsarscov2vaccinesincmlpatientsaprospectivestudyofabraziliancenter